V-Wave Ltd. founded in 2010 the company is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with chronic Heart Failure (HF).
As a leading cause of death and hospitalization, HF continues to affect millions of people worldwide. V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment.
V-Wave has developed a proprietary unidirectional inter-atrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.
The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.